Biocept reports inducement grants under nasdaq listing rule 5635(c)(4)

San diego--(business wire)--biocept, inc. (nasdaq: bioc), a leading provider of molecular diagnostic assays, products and services, today announced that it has granted an inducement stock option to purchase 134,550 shares of its common stock to darrell taylor, its new senior vice president, general counsel and chief compliance officer. the inducement stock option has a grant date of february 28, 2022, and was granted as an inducement material to mr. taylor's entering into employment with biocep
BIOC Ratings Summary
BIOC Quant Ranking